Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474 Hold
10
﹤0.01% 227
2025
Q4
$684 Hold
10
﹤0.01% 235
2025
Q3
$721 Hold
10
﹤0.01% 234
2025
Q2
$779 Hold
10
﹤0.01% 253
2025
Q1
$814 Hold
10
﹤0.01% 263
2024
Q4
$899 Hold
10
﹤0.01% 272
2024
Q3
$621 Hold
10
﹤0.01% 276
2024
Q2
$535 Hold
10
﹤0.01% 272
2024
Q1
$596 Hold
10
﹤0.01% 267
2023
Q4
$595 Hold
10
﹤0.01% 262
2023
Q3
$420 Hold
10
﹤0.01% 266
2023
Q2
$511 Hold
10
﹤0.01% 269
2023
Q1
$583 Hold
10
﹤0.01% 265
2022
Q4
$554 Buy
+10
New +$487 ﹤0.01% 244

Other funds holding DOCU

MB, Levis & Associates's DOCU Position: Q1 2026 in Review

MB, Levis & Associates held its DocuSign (DOCU) position steady in Q1 2026 at 10 shares worth $474. The position accounts for ﹤0.01% of the portfolio, ranked #227.

MB, Levis & Associates first reported a position in DOCU in Q4 2022 and has held it in 14 quarters since. The position peaked at $899 in Q4 2024. 703 funds tracked by Wall St. Rank hold DOCU as of Q1 2026.

  • MB, Levis & Associates held 10 shares of DocuSign worth $474 as of Q1 2026.
  • MB, Levis & Associates left its DocuSign share count unchanged in Q1 2026.
  • DocuSign made up ﹤0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #227 holding.
  • MB, Levis & Associates first reported a position in DocuSign in Q4 2022 and has held it in 14 quarters since.
  • MB, Levis & Associates's DocuSign position peaked at $899 in Q4 2024.
  • 703 funds tracked by Wall St. Rank held DocuSign as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.